Back to dashboard
CommercialCoverageMedium impact

New policies

Blue Cross Blue Shield of Rhode Island·RI · Oncology, Rheumatology, Psychiatry·Physician / Facility
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply
—

Summary

BCBS Rhode Island has created three new medical policies for Evenity (romosozumab-aqqg), Polivy (polatuzumab vedotin-piiq), and Spravato (esketamine). These policies have varying effective dates and full details must be reviewed on the provider website under Medical Policy heading.

Action Required

Action needed
Immediately: Billing team must access bcbsri.com Provider section under Medical Policy heading to review full policy text for Evenity (romosozumab-aqqg), Polivy (polatuzumab vedotin-piiq), and Spravato (esketamine). Note the varying effective dates for each policy and update billing procedures accordingly for coverage determinations and prior authorization requirements.

Related policy hubs